检索

标题
作者
A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory
Bolotskaya L., Bessmertnaya E., Shestakova M., Shamkhalova M., Nikankina L., Ilyin A., Glek I., Zolotukhin A., Dedov I.
Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
Ametov A., Kamynina L., Akhmedova Z.
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V., Klimontov V., Myakina N., Tyan N., Fazullina O., Romanov V.
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A., Gusenbekova D.
Relationships between serum lipid composition and acetylator status as markers of energy metabolism in women with coronary heart disease, metabolic syndrome, and type 2 diabetes mellitus
Matveeva S.
Heterogenicity of type 2 diabetes mellitus: clinical characteristics of 4 subtypes
Asfandiyarova N., Asfandiyarova N.
Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS
Eliseev M., Barskova V., Eliseev M., Barskova V.
Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
Teplyakov A., Torim Y., Kuznetsova A., Rybal'chenko E., Krylov A., Karpov R., Teplyakov A., Torim Y., Kuznetsova A., Rybalchenko E., Krylov A., Karpov R.
The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy
Ametov A., Demidova T., Smagina L.
Assessment of vasomotor endothelial function inpatients with diabetes mellitus type l at different stages ofdiabetic nephropathy
Shestakova M., Yarek-Martynov I., Ivanishina N., Dedov I.
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes
Verner V., Mel’nik M., Knjazeva S.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
Gene therapy of type 2 diabetes mellitus: state of art
Stafeev Y., Menshikov M., Parfyonova Y.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M., Glazunova A., Mikhaleva O., Zuraeva Z., Martynov S., Klefortova I., Manchenko O., Ulyanova I., Ilyin A., Shamkhalova M., Shestakova M.
Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention
Shishkova V.
Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
Statsenko M., Derevianchenko M., Ostrovskiĭ O., Titarenko M., Shvets M., Bondarev A.
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A., Kamynina L., Ametov A., Kamynina L.
Contribution of obesity to renal lesion in patients with type 2 diabetes mellitus
Kutyrina I., Savelyeva S., Kryachkova A., Shestakova M.
Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity
Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P., Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P.
Role of insulin resistance in pathogenesis of diabetes mellitus type 2
Balabolkin M., Klebanova E., hanov О., Lomonosov К.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I., Severina A., Shamkhalova M., Shestakova M.
Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
Dedov I., Melnichenko G., Troshina E., Ershova E., Mazurina N., Ogneva N., Yashkov Y., Ilyin А.
Chronic constipation in the practice of a therapist: Features of therapy for comorbidity
Svistunov A., Osadchuk M., Butorova L., Tokmulina G.
Intercurrent and autoimmune processes in type 1 diabetes mellitus
Derevyanko O., Nikonova T., Smirnova O., Dedov I.
Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm Region after 10 years
Tereshchenko I., Suslina A.
A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition
Shestakova M., Sukhareva O., Chernova T., Shmushkovich I., Aleksandrov A., Il'in A., Dedov I.
Carbohydrate metabolic disturbances and obstructive sleep apnea syndrome
Oleĭnikov V., Sergatskaia N.
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism
Lavrenko A., Shlykova O., Kutsenko L., Mamontova T., Kaĭdashev I.
Impact of insulin therapy on insulin resistance and a risk for coronary heart disease and cardiovascular death in patients with type 2 diabetes
Ametov A., Kochergina I., Ulanova K., Ametov A., Kochergina I., Ulanova K.
Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
Teplyakov A., Mayanskaya S., Bolotskaya L., Vdovina T., Stepacheva T., Kuznetsova A., Lukinov A., Derbeneva N., Frants M., Shilov S., Teplyakov A., Mayanskaya S., Bolotskaya L., Vdovina T., Stepacheva T., Kuznetsova A., Lukinov A., Derbeneva N., Frants M., Shilov S.
Metabolic syndrome of insulin resistance: basic conception and consequences (a review)
Starkova N., Dvoryashina I.
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
Sklyanik I., Shestakova M.
Gut microbiota is a factor of risk for obesity and type 2 diabetes
Demidova T., Lobanova K., Oinotkinova O.
The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD)
Panevina A., Smetneva N., Vasilenko A., Shestakova M.
New aspects of Helicobacter pylori infection: Association with metabolic disturbances
German S., Bobrovnitsky I.
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
Bakulin I., Sandler Y., Vinnitskayа E., Keiyan V., Rodionova S., Rotin D.
Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
Efremova N., Bolotskaya L., Atarshchikov D., Bondarenko O., Ilyin A., Shestakova M.
Thyroid dysfunction in patients with type 2 diabetes mellitus
Tereshchenko I., Suslina A.
Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
Shestakova E., Il'in A., Shestakova M., Dedov I.
Osteoarthrosis in patients with type 2 diabetes mellitus
Asfandiiarova N., Nizov A., Nekhaeva T., Sakaeva N., Filatova T., Zhuravleva N., Trunina T.
СРАР therapy for obstructive sleep apnea syndrome in patients with carbohydrate metabolic disturbances and type 2 diabetes mellitus
Oleĭnikov V., Sergatskaia N.
Cytokine gene polymorphism in type 2 diabetes mellitus in the Europeoid women of Russia
Konenkov V., Korolev M., Shevchenko A., Lapsina S., Koroleva E., Zonova E., Prokof'ev V.
Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
Ametov A., Pyanykh O., Chernikova N.
Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes
Shvarts V., Schwarz V.
Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
Chazova I., Mychka V., Duishvili D.
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.
The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus
Chernikova N., Kamynina L., Ametov A., Sychev D., Grishina E., Ryzhikova K.
Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
Genkel V., Salashenko A., Shamaeva T., Sumerkina V., Nikushkina K., Shaposhnik I.
Nephrolithiasis against type 2 diabetes mellitus: on the effect of hypoglycemic therapy on lithogenesis
Yarovoy S., Kareva E., Djalilov O.
Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms
Isakova Z., Talaibekova E., Asambaeva D., Kerimkulova A., Lunegova O., Aldasheva N., Aldashev A.
51 - 100 的 119 信息 << < 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##